163 related articles for article (PubMed ID: 1435900)
1. A less costly regimen of alglucerase to treat Gaucher's disease.
Figueroa ML; Rosenbloom BE; Kay AC; Garver P; Thurston DW; Koziol JA; Gelbart T; Beutler E
N Engl J Med; 1992 Dec; 327(23):1632-6. PubMed ID: 1435900
[TBL] [Abstract][Full Text] [Related]
2. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.
Hollak CE; Aerts JM; Goudsmit R; Phoa SS; Ek M; van Weely S; von dem Borne AE; van Oers MH
Lancet; 1995 Jun; 345(8963):1474-8. PubMed ID: 7769902
[TBL] [Abstract][Full Text] [Related]
3. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
Whittington R; Goa KL
Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294
[TBL] [Abstract][Full Text] [Related]
4. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.
Zimran A; Elstein D; Kannai R; Zevin S; Hadas-Halpern I; Levy-Lahad E; Cohen Y; Horowitz M; Abrahamov A
Am J Med; 1994 Jul; 97(1):3-13. PubMed ID: 8030654
[TBL] [Abstract][Full Text] [Related]
5. Alglucerase. A review of its therapeutic use in Gaucher's disease.
Whittington R; Goa KL
Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
[TBL] [Abstract][Full Text] [Related]
6. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
Pérez-Calvo JI; Giraldo P; Giralt M
Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy for Gaucher's disease.
Beutler E
Baillieres Clin Haematol; 1997 Dec; 10(4):751-63. PubMed ID: 9497862
[TBL] [Abstract][Full Text] [Related]
8. Replacement therapy with imiglucerase for type 1 Gaucher's disease.
Zimran A; Elstein D; Levy-Lahad E; Zevin S; Hadas-Halpern I; Bar-Ziv Y; Foldes J; Schwartz AJ; Abrahamov A
Lancet; 1995 Jun; 345(8963):1479-80. PubMed ID: 7769903
[TBL] [Abstract][Full Text] [Related]
9. Gaucher's disease: a review.
Morales LE
Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
[TBL] [Abstract][Full Text] [Related]
10. Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1.
Pérez-Calvo J; Giraldo P; Pastores GM; Fernández-Galán M; Martín-Nuñez G; Pocoví M
J Postgrad Med; 2003; 49(2):127-31. PubMed ID: 12867687
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
MacKenzie JJ; Amato D; Clarke JT
CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
[TBL] [Abstract][Full Text] [Related]
12. [Enzyme replacement therapy: a new treatment concept in Gaucher disease].
Beck M; Mengel E; Barone R
Wien Klin Wochenschr; 1997 Feb; 109(3):81-5. PubMed ID: 9139464
[TBL] [Abstract][Full Text] [Related]
13. Enzyme replacement treatment in type 1 and type 3 Gaucher's disease.
Bembi B; Zanatta M; Carrozzi M; Baralle F; Gornati R; Berra B; Agosti E
Lancet; 1994 Dec; 344(8938):1679-82. PubMed ID: 7996964
[TBL] [Abstract][Full Text] [Related]
14. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
[TBL] [Abstract][Full Text] [Related]
15. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
Cox T; Lachmann R; Hollak C; Aerts J; van Weely S; Hrebícek M; Platt F; Butters T; Dwek R; Moyses C; Gow I; Elstein D; Zimran A
Lancet; 2000 Apr; 355(9214):1481-5. PubMed ID: 10801168
[TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.
Niederau C; Holderer A; Heintges T; Strohmeyer G
J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809
[TBL] [Abstract][Full Text] [Related]
17. Alglucerase for Gaucher's disease: dose, costs and benefits.
Beutler E; Garber AM
Pharmacoeconomics; 1994 Jun; 5(6):453-9. PubMed ID: 10147261
[No Abstract] [Full Text] [Related]
18. The clinical course of treated and untreated Gaucher disease. A study of 45 patients.
Beutler E; Demina A; Laubscher K; Garver P; Gelbart T; Balicki D; Vaughan L
Blood Cells Mol Dis; 1995; 21(2):86-108. PubMed ID: 8846048
[TBL] [Abstract][Full Text] [Related]
19. [Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy].
Dann K; Althaus C; Kersten A; vom Dahl S; Sundmacher R
Klin Monbl Augenheilkd; 1998 Dec; 213(6):358-61. PubMed ID: 10048015
[TBL] [Abstract][Full Text] [Related]
20. [Type I Gaucher's disease: clinical, evolutive and therapeutic features in 8 cases].
Giraldo P; Pérez-Calvo J; Cortés T; Civeira F; Rubio-Félix D
Sangre (Barc); 1994 Feb; 39(1):3-7. PubMed ID: 8197516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
